Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Bausch & Lomb Corp (BLCO)

Bausch & Lomb Corp (BLCO)
16.35 -0.06 (-0.37%) 02/18/25 [NYSE]
16.10 x 3 16.88 x 10
Realtime by (Cboe BZX)
16.10 x 3 16.88 x 10
Realtime 16.35 unch (unch) 16:00 ET
Quote Overview for Tue, Feb 18th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
16.25
Day High
16.48
Open 16.35
Previous Close 16.41 16.41
Volume 605,238 605,238
Avg Vol 737,935 737,935
Stochastic %K 24.24% 24.24%
Weighted Alpha -13.69 -13.69
5-Day Change +0.11 (+0.68%) +0.11 (+0.68%)
52-Week Range 13.16 - 21.69 13.16 - 21.69
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,784,016
  • Shares Outstanding, K 352,469
  • Annual Sales, $ 4,146 M
  • Annual Income, $ -260,000 K
  • EBIT $ 424 M
  • EBITDA $ 836 M
  • 60-Month Beta 0.46
  • Price/Sales 1.23
  • Price/Cash Flow 8.72
  • Price/Book 0.88
  • Price/Earnings ttm 27.28
  • Earnings Per Share ttm 0.61
  • Most Recent Earnings $0.17 on 10/30/24
  • Next Earnings Date 02/19/25 [BMO]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING:

    SIC-3851 Ophthalmic Goods

    Medical Services

Options Overview Details

View History
  • Implied Volatility 50.42% ( -4.87%)
  • Historical Volatility 34.92%
  • IV Percentile 69%
  • IV Rank 48.08%
  • IV High 90.32% on 07/26/24
  • IV Low 13.47% on 05/14/24
  • Put/Call Vol Ratio 0.93
  • Today's Volume 1,782
  • Volume Avg (30-Day) 448
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 15,751
  • Open Int (30-Day) 15,277

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.23
  • Number of Estimates 8
  • High Estimate 0.27
  • Low Estimate 0.21
  • Prior Year 0.24
  • Growth Rate Est. (year over year) -4.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.83 +3.28%
on 02/10/25
Period Open: 17.36
18.14 -9.87%
on 01/30/25
-1.01 (-5.82%)
since 01/17/25
3-Month
15.83 +3.28%
on 02/10/25
Period Open: 19.76
20.71 -21.05%
on 12/10/24
-3.41 (-17.26%)
since 11/18/24
52-Week
13.16 +24.24%
on 05/02/24
Period Open: 14.31
21.69 -24.62%
on 10/14/24
+2.04 (+14.26%)
since 02/16/24

Most Recent Stories

More News
Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect

Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect

INSP : 180.08 (-2.98%)
BLCO : 16.35 (-0.37%)
HAE : 64.09 (+2.77%)
Bausch Health Provides Update on Strategic Alternatives

LAVAL, QC / ACCESS Newswire / February 6, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), a global, diversified pharmaceutical company enriching lives through...

BLCO.TO : 23.09 (-1.45%)
BHC.TO : 9.03 (+3.44%)
BLCO : 16.35 (-0.37%)
BHC : 6.36 (+3.25%)
Bausch + Lomb: Q3 Earnings Snapshot

Bausch + Lomb: Q3 Earnings Snapshot

BLCO : 16.35 (-0.37%)
Why Bausch + Lomb Stock Soared by Over 7% on Monday

It was quite a busy and eventful day for the company.

BX : 166.74 (+1.15%)
BLCO : 16.35 (-0.37%)
TPG : 60.22 (+1.41%)
GS : 672.19 (+1.76%)
Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value

The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden.

ALC : 89.45 (-0.67%)
BLCO : 16.35 (-0.37%)
BHC : 6.36 (+3.25%)
Here's Why Bausch Health Stock Gained 14.7% in a Week

Shares of Bausch Health, Inc. BHC gained 14.7% in a week on reports of refinancing its debt to enable the impending sale of its eye care company, Bausch + Lomb BLCO. The industry declined 0.6% during this...

KRYS : 156.69 (+2.25%)
FULC : 3.77 (+2.17%)
BLCO : 16.35 (-0.37%)
BHC : 6.36 (+3.25%)
Why Bausch + Lomb Rallied Today

The highly indebted healthcare stock rose on rumors it may be selling itself.

BLCO : 16.35 (-0.37%)
Bausch + Lomb: Q2 Earnings Snapshot

Bausch + Lomb: Q2 Earnings Snapshot

BLCO : 16.35 (-0.37%)
This Bausch Health Companies Unusually Active Option Is a No-Brainer

Bausch Health Companies had the 8th-highest Vol/OI ratio in Wednesday trading. The pharmaceutical company’s unusual options activity suggests it might have more gains ahead.

BHC : 6.36 (+3.25%)
BLCO : 16.35 (-0.37%)
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030

EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END

OKYO : 1.0900 (-0.46%)
ALC : 89.45 (-0.67%)
BLCO : 16.35 (-0.37%)
JNJ : 154.99 (+0.05%)
RHHBY : 40.8500 (-0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R)....

See More

Key Turning Points

3rd Resistance Point 16.70
2nd Resistance Point 16.59
1st Resistance Point 16.47
Last Price 16.35
1st Support Level 16.24
2nd Support Level 16.13
3rd Support Level 16.01

See More

52-Week High 21.69
Fibonacci 61.8% 18.43
Fibonacci 50% 17.42
Fibonacci 38.2% 16.42
Last Price 16.35
52-Week Low 13.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Increase Profitable Opportunities with Barchart's Technical Opinion